These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 32957517)
21. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors. Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881 [TBL] [Abstract][Full Text] [Related]
22. One-pot synthesis of podophyllotoxin-thiourea congeners by employing NH₂SO₃H/NaI: Anticancer activity, DNA topoisomerase-II inhibition, and apoptosis inducing agents. Shankaraiah N; Kumar NP; Amula SB; Nekkanti S; Jeengar MK; Naidu VG; Reddy TS; Kamal A Bioorg Med Chem Lett; 2015 Oct; 25(19):4239-44. PubMed ID: 26292628 [TBL] [Abstract][Full Text] [Related]
23. 4β-amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIα inhibition and potential anticancer agents for prostate cancer. Reddy VG; Bonam SR; Reddy TS; Akunuri R; Naidu VGM; Nayak VL; Bhargava SK; Kumar HMS; Srihari P; Kamal A Eur J Med Chem; 2018 Jan; 144():595-611. PubMed ID: 29289884 [TBL] [Abstract][Full Text] [Related]
24. Antitumor agents. I. DNA topoisomerase II inhibitory activity and the structural relationship of podophyllotoxin derivatives as antitumor agents. Terada T; Fujimoto K; Nomura M; Yamashita J; Kobunai T; Takeda S; Wierzba K; Yamada Y; Yamaguchi H Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2720-7. PubMed ID: 1334447 [TBL] [Abstract][Full Text] [Related]
25. 4β-[4'-(1-(Aryl)ureido)benzamide]podophyllotoxins as DNA topoisomerase I and IIα inhibitors and apoptosis inducing agents. Kamal A; Suresh P; Ramaiah MJ; Srinivasa Reddy T; Kapavarapu RK; Rao BN; Imthiajali S; Lakshminarayan Reddy T; Pushpavalli SN; Shankaraiah N; Pal-Bhadra M Bioorg Med Chem; 2013 Sep; 21(17):5198-208. PubMed ID: 23849207 [TBL] [Abstract][Full Text] [Related]
26. Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues. Desbène S; Giorgi-Renault S Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):71-90. PubMed ID: 12678752 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives. Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of d-ring modified acid hydrazide derivatives of podophyllotoxin and their anticancer studies as Tubulin inhibiting agents. Nerella S; Kankala S; Paidakula S; Gavaji B Bioorg Chem; 2020 Jan; 94():103384. PubMed ID: 31776036 [TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of the novel DNA topoisomerase II inhibitors: esterification and amination substituted 4'-demethylepipodophyllotoxin derivates exhibiting anti-tumor activity by activating ATM/ATR signaling pathways. Xiao L; Zhao W; Li HM; Wan DJ; Li DS; Chen T; Tang YJ Eur J Med Chem; 2014 Jun; 80():267-77. PubMed ID: 24793877 [TBL] [Abstract][Full Text] [Related]
31. Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization. Ma Y; Fang S; Li H; Han C; Lu Y; Zhao Y; Liu Y; Zhao C Chem Biol Drug Des; 2013 Jul; 82(1):12-21. PubMed ID: 23786349 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors. Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156 [TBL] [Abstract][Full Text] [Related]
33. Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells. Kandil S; Wymant JM; Kariuki BM; Jones AT; McGuigan C; Westwell AD Eur J Med Chem; 2016 Mar; 110():311-25. PubMed ID: 26854430 [TBL] [Abstract][Full Text] [Related]
34. 4'-Demethyl-deoxypodophyllotoxin glucoside isolated from Podophyllum hexandrum exhibits potential anticancer activities by altering Chk-2 signaling pathway in MCF-7 breast cancer cells. Zilla MK; Nayak D; Amin H; Nalli Y; Rah B; Chakraborty S; Kitchlu S; Goswami A; Ali A Chem Biol Interact; 2014 Dec; 224():100-7. PubMed ID: 25446499 [TBL] [Abstract][Full Text] [Related]
35. Podoverine A--a novel microtubule destabilizing natural product from the Podophyllum species. Tran TT; Gerding-Reimers C; Schölermann B; Stanitzki B; Henkel T; Waldmann H; Ziegler S Bioorg Med Chem; 2014 Sep; 22(18):5110-6. PubMed ID: 24530033 [TBL] [Abstract][Full Text] [Related]
36. Synthesis of a terphenyl substituted 4-aza-2,3-didehydropodophyllotoxin analogues as inhibitors of tubulin polymerization and apoptosis inducers. Kamal A; Tamboli JR; Nayak VL; Adil SF; Vishnuvardhan MV; Ramakrishna S Bioorg Med Chem; 2014 May; 22(9):2714-23. PubMed ID: 24721832 [TBL] [Abstract][Full Text] [Related]
37. Discovery of a Series of Acridinones as Mechanism-Based Tubulin Assembly Inhibitors with Anticancer Activity. Magalhaes LG; Marques FB; da Fonseca MB; Rogério KR; Graebin CS; Andricopulo AD PLoS One; 2016; 11(8):e0160842. PubMed ID: 27508497 [TBL] [Abstract][Full Text] [Related]
38. Antitumor agents. Part 227: Studies on novel 4'-O-demethyl-epipodophyllotoxins as antitumor agents targeting topoisomerase II. Xiao Z; Bastow KF; Vance JR; Lee KH Bioorg Med Chem; 2004 Jun; 12(12):3339-44. PubMed ID: 15158802 [TBL] [Abstract][Full Text] [Related]